Corient Private Wealth LLC Has $18.82 Million Stock Holdings in STERIS plc (NYSE:STE)

Corient Private Wealth LLC reduced its position in shares of STERIS plc (NYSE:STE) by 9.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 91,528 shares of the medical equipment provider’s stock after selling 9,647 shares during the period. Corient Private Wealth LLC owned about 0.09% of STERIS worth $18,815,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Magnolia Capital Advisors LLC raised its stake in shares of STERIS by 1.9% in the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock valued at $521,000 after acquiring an additional 48 shares during the last quarter. SkyView Investment Advisors LLC grew its position in STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock worth $765,000 after acquiring an additional 51 shares during the last quarter. Park Edge Advisors LLC grew its position in STERIS by 1.1% during the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock worth $958,000 after acquiring an additional 51 shares during the last quarter. Citizens Financial Group Inc. RI grew its position in STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock worth $201,000 after acquiring an additional 54 shares during the last quarter. Finally, Opal Wealth Advisors LLC grew its position in STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock worth $230,000 after acquiring an additional 60 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Up 0.2 %

Shares of STE opened at $228.29 on Wednesday. The firm has a market capitalization of $22.43 billion, a price-to-earnings ratio of 48.47 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The business’s fifty day moving average price is $220.09 and its two-hundred day moving average price is $222.22. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, analysts predict that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

Wall Street Analyst Weigh In

A number of research firms recently commented on STE. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Stephens restated an “overweight” rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler increased their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, STERIS has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.